百克生物：公司对带状疱疹疫苗的销售定价进行了主动、审慎的优化调整

Core Viewpoint - The company has proactively and prudently adjusted the pricing of its shingles vaccine to activate market potential and fulfill corporate social responsibility, aiming to alleviate the economic burden of vaccination, especially for the elderly population [1] Group 1 - The company is focused on expanding the coverage of its shingles vaccine among target populations, particularly the middle-aged and elderly [1] - The company is enhancing its market penetration by improving channel distribution and increasing terminal coverage [1] - The adjustments in pricing are intended to promote broader access to the vaccine while maintaining existing product coverage [1]